Philadelphia-positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID-19 pandemic: a Campus ALL study

Br J Haematol. 2020 Jul;190(1):e3-e5. doi: 10.1111/bjh.16758. Epub 2020 Jun 14.

¹ Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
² Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
³ Department of Hematology/Oncology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.
⁴ Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
⁵ Dipartimento di Scienze Cliniche e Biologiche, Università di Torino, Torino, Italy.
⁶ Department of Medical Sciences, Section of Hematology, University of Ferrara, Ferrara, Italy.
⁷ Division of Haematology and Stem Cell Transplantation Unit, Cardarelli Hospital, Napoli, Italy.

No abstract available

Keywords: COVID-19; Ph+ acute lymphoblastic leukaemia; management; tyrosine kinase inhibitors.

Publication types